| __timestamp | Lantheus Holdings, Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 13673000 | 382096000000 |
| Thursday, January 1, 2015 | 14358000 | 345927000000 |
| Friday, January 1, 2016 | 12203000 | 312303000000 |
| Sunday, January 1, 2017 | 18125000 | 325441000000 |
| Monday, January 1, 2018 | 17071000 | 368298000000 |
| Tuesday, January 1, 2019 | 20018000 | 492381000000 |
| Wednesday, January 1, 2020 | 32788000 | 455833000000 |
| Friday, January 1, 2021 | 44966000 | 526087000000 |
| Saturday, January 1, 2022 | 311681000 | 633325000000 |
| Sunday, January 1, 2023 | 77707000 | 729924000000 |
| Monday, January 1, 2024 | 729924000000 |
Data in motion
In the ever-evolving world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Takeda Pharmaceutical Company Limited and Lantheus Holdings, Inc. have demonstrated contrasting approaches to R&D investment. Takeda, a global leader, has consistently allocated substantial resources, with R&D expenses peaking at approximately 730 billion yen in 2023, marking a 91% increase since 2014. In contrast, Lantheus Holdings, a smaller player, has shown a more volatile pattern, with a remarkable surge in 2022, where R&D expenses increased by over 600% compared to 2014. This divergence highlights the strategic differences between a global giant and a nimble innovator. As we look to the future, these investments will likely shape the landscape of pharmaceutical advancements, driving breakthroughs that could redefine healthcare.
Gross Profit Trends Compared: Takeda Pharmaceutical Company Limited vs Lantheus Holdings, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and CymaBay Therapeutics, Inc.
Analyzing R&D Budgets: Takeda Pharmaceutical Company Limited vs Amicus Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and Soleno Therapeutics, Inc.
Comparing Innovation Spending: Takeda Pharmaceutical Company Limited and MannKind Corporation
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and Travere Therapeutics, Inc.
Takeda Pharmaceutical Company Limited or Viridian Therapeutics, Inc.: Who Invests More in Innovation?
BioMarin Pharmaceutical Inc. or Lantheus Holdings, Inc.: Who Invests More in Innovation?
R&D Insights: How Lantheus Holdings, Inc. and Protagonist Therapeutics, Inc. Allocate Funds
Comparing Innovation Spending: Lantheus Holdings, Inc. and MorphoSys AG
R&D Insights: How Lantheus Holdings, Inc. and Agios Pharmaceuticals, Inc. Allocate Funds
Lantheus Holdings, Inc. or Viridian Therapeutics, Inc.: Who Invests More in Innovation?